Certified by Founder
Lodge
Oorja Bio
start up
United States
- Houston, Texas
- 22/05/2026
- Series A
- $30,000,000
Oorja's goal is to develop groundbreaking therapies for cardiopulmonary and fibrotic disorders that target the underlying pathophysiology of disease.
By addressing key pathways, our medicines promote cellular repair, reverse and or remodel fibrotic tissue, going beyond symptom management to establish a new therapeutic standard of care.
Our success is driven by an experienced team with a proven track record in pulmonary drug development, commercialization, and high-value transactions.
- Industry Biotechnology Research
- Website https://oorjabio.com/
- LinkedIn https://www.linkedin.com/company/oorja-bio/
Forage | $40,000,000 | (Jun 5, 2026)
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Terra AI | $20,000,000 | (Jun 5, 2026)
Town | $55,000,000 | (Jun 5, 2026)
Lassie | $35,000,000 | (Jun 5, 2026)
OFFROAD | $7,000,000 | (Jun 5, 2026)
Shifters | $10,200,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Scispot | $8,000,000 | (Jun 5, 2026)
Scotch | $20,000,000 | (Jun 5, 2026)